Trichomonas vaginalis Prevalence in the United States, 2013-2016
Among noninstitutionalized adolescents and adults in the United States between 2013 and 2016, 1.3% tested positive for Trichomonas vaginalis infection.
Sexually Transmitted Infections
Gentamicin Appropriate Second-Line Therapy to Ceftriaxone for Gonorrhea
Two weeks after treatment, infection cleared for 98, 91% treated with ceftriaxone vs gentamicin.
Prevalence of Extragenital STDs High in Men Who Have Sex With Men
Extragenital (rectal and pharyngeal) chlamydia and gonorrhea are prevalent among men who have sex with men.
Stat Consult: Human Immunodeficiency Virus (HIV)
Growing evidence supports starting individuals on antiretroviral therapy as soon as they are diagnosed with HIV to improve mortality rates.
Prevalence of Anogenital Warts Declining Across Populations
The prevalence of anogenital warts has decreased, with significant declines observed in specific populations.
Zoliflodacin: Promising New Treatment for Urogenital Gonorrhea
Zoliflodacin was effective in treating gonococcal urogenital and rectal infections, but less effective in the treatment of pharyngeal gonorrhea.
NYC Sexual Health Clinics See Rise in Anorectal Lymphogranuloma Venereum
A rise in anorectal lymphogranuloma venereum, caused by Chlamydia trachomatis invasive serovars, observed from 2012-2015 in NYC sexual health clinics.
Gepotidacin Shows Potential in Treating Resistant Neisseria Gonorrhoeae
Gepotidacin, a novel triazaacenaphthelene bacterial type II topoisomerase inhibitor shows potential in treating resistant Neisseria gonorrhoeae.
New Antibiotic Shows Promise as Potential Treatment for Uncomplicated Gonorrhea
Unlike other antibiotics used to treat gonorrhea, zoliflodacin, a spiropyrimidinetrione antimicrobial agent, works by inhibiting DNA biosynthesis by arresting the cleaved covalent gyrase complex, thereby impeding bacterial growth.
2014 to 2016 Saw 470% Increase in HIV PrEP Use in US
Seven percent of those with indications for PrEP were prescribed PrEP, including 2.1% of women.
Next post in HIV/AIDS Information Center
